Influence of Antihypertensive Therapy on Cerebral Perfusion in Patients with Metabolic Syndrome: Relationship with Cognitive Function and 24-h Arterial Blood Pressure Monitoring

Nataliya Yurievna Efimova, Vladimir I. Chernov, Irina Y. Efimova, Yuri B. Lishmanov

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aims: To investigate the regional cerebral blood flow, cognitive function, and parameters of 24-h arterial blood pressure monitoring in patients with metabolic syndrome before and after combination antihypertensive therapy. Methods: The study involved 54 patients with metabolic syndrome (MetS) investigated by brain single-photon emission computed tomography, 24-h blood pressure monitoring (ABPM), and comprehensive neuropsychological testing before and after 24 weeks of combination antihypertensive therapy. Results: Patients with metabolic syndrome had significantly poorer regional cerebral blood flow compared with control group: by 7% (P = 0.003) in right anterior parietal cortex, by 6% (P = 0.028) in left anterior parietal cortex, by 8% (P = 0.007) in right superior frontal lobe, and by 10% (P = 0.00002) and 7% (P = 0.006) in right and left temporal brain regions, correspondingly. The results of neuropsychological testing showed 11% decrease in mentation (P = 0.002), and 19% (P = 0.011) and 20% (P = 0.009) decrease in immediate verbal and visual memory in patients with MetS as compared with control group. Relationships between the indices of ABPM, cerebral perfusion, and cognitive function were found. Data showed an improvement of regional cerebral blood flow, ABPM parameters, and indicators of cognitive functions after 6 months of antihypertensive therapy in patients with MetS. Conclusion: The study showed the presence of diffuse disturbances in cerebral perfusion is associated with cognitive disorders in patients with metabolic syndrome. Combination antihypertensive treatment exerts beneficial effects on the 24-h blood pressure profile, increases cerebral blood flow, and improves cognitive function in patients with MetS.

Original languageEnglish
Pages (from-to)209-215
Number of pages7
JournalCardiovascular Therapeutics
Volume33
Issue number4
DOIs
Publication statusPublished - 1 Aug 2015

Fingerprint

Cerebrovascular Circulation
Cognition
Antihypertensive Agents
Arterial Pressure
Perfusion
Regional Blood Flow
Somatosensory Cortex
Therapeutics
Metabolic Brain Diseases
Blood Pressure
Control Groups
Physiologic Monitoring
Frontal Lobe
Temporal Lobe
Single-Photon Emission-Computed Tomography
Brain

Keywords

  • Antihypertensive treatment
  • Brain perfusion
  • Circadian rhythm of blood pressure
  • Cognitive function
  • Metabolic syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Influence of Antihypertensive Therapy on Cerebral Perfusion in Patients with Metabolic Syndrome : Relationship with Cognitive Function and 24-h Arterial Blood Pressure Monitoring. / Efimova, Nataliya Yurievna; Chernov, Vladimir I.; Efimova, Irina Y.; Lishmanov, Yuri B.

In: Cardiovascular Therapeutics, Vol. 33, No. 4, 01.08.2015, p. 209-215.

Research output: Contribution to journalArticle

@article{aa214851b0c141afa2babb288e30d586,
title = "Influence of Antihypertensive Therapy on Cerebral Perfusion in Patients with Metabolic Syndrome: Relationship with Cognitive Function and 24-h Arterial Blood Pressure Monitoring",
abstract = "Aims: To investigate the regional cerebral blood flow, cognitive function, and parameters of 24-h arterial blood pressure monitoring in patients with metabolic syndrome before and after combination antihypertensive therapy. Methods: The study involved 54 patients with metabolic syndrome (MetS) investigated by brain single-photon emission computed tomography, 24-h blood pressure monitoring (ABPM), and comprehensive neuropsychological testing before and after 24 weeks of combination antihypertensive therapy. Results: Patients with metabolic syndrome had significantly poorer regional cerebral blood flow compared with control group: by 7{\%} (P = 0.003) in right anterior parietal cortex, by 6{\%} (P = 0.028) in left anterior parietal cortex, by 8{\%} (P = 0.007) in right superior frontal lobe, and by 10{\%} (P = 0.00002) and 7{\%} (P = 0.006) in right and left temporal brain regions, correspondingly. The results of neuropsychological testing showed 11{\%} decrease in mentation (P = 0.002), and 19{\%} (P = 0.011) and 20{\%} (P = 0.009) decrease in immediate verbal and visual memory in patients with MetS as compared with control group. Relationships between the indices of ABPM, cerebral perfusion, and cognitive function were found. Data showed an improvement of regional cerebral blood flow, ABPM parameters, and indicators of cognitive functions after 6 months of antihypertensive therapy in patients with MetS. Conclusion: The study showed the presence of diffuse disturbances in cerebral perfusion is associated with cognitive disorders in patients with metabolic syndrome. Combination antihypertensive treatment exerts beneficial effects on the 24-h blood pressure profile, increases cerebral blood flow, and improves cognitive function in patients with MetS.",
keywords = "Antihypertensive treatment, Brain perfusion, Circadian rhythm of blood pressure, Cognitive function, Metabolic syndrome",
author = "Nataliya Yurievna Efimova and Chernov, {Vladimir I.} and Efimova, {Irina Y.} and Lishmanov, {Yuri B.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1111/1755-5922.12136",
language = "English",
volume = "33",
pages = "209--215",
journal = "Cardiovascular Therapeutics",
issn = "1755-5914",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Influence of Antihypertensive Therapy on Cerebral Perfusion in Patients with Metabolic Syndrome

T2 - Relationship with Cognitive Function and 24-h Arterial Blood Pressure Monitoring

AU - Efimova, Nataliya Yurievna

AU - Chernov, Vladimir I.

AU - Efimova, Irina Y.

AU - Lishmanov, Yuri B.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Aims: To investigate the regional cerebral blood flow, cognitive function, and parameters of 24-h arterial blood pressure monitoring in patients with metabolic syndrome before and after combination antihypertensive therapy. Methods: The study involved 54 patients with metabolic syndrome (MetS) investigated by brain single-photon emission computed tomography, 24-h blood pressure monitoring (ABPM), and comprehensive neuropsychological testing before and after 24 weeks of combination antihypertensive therapy. Results: Patients with metabolic syndrome had significantly poorer regional cerebral blood flow compared with control group: by 7% (P = 0.003) in right anterior parietal cortex, by 6% (P = 0.028) in left anterior parietal cortex, by 8% (P = 0.007) in right superior frontal lobe, and by 10% (P = 0.00002) and 7% (P = 0.006) in right and left temporal brain regions, correspondingly. The results of neuropsychological testing showed 11% decrease in mentation (P = 0.002), and 19% (P = 0.011) and 20% (P = 0.009) decrease in immediate verbal and visual memory in patients with MetS as compared with control group. Relationships between the indices of ABPM, cerebral perfusion, and cognitive function were found. Data showed an improvement of regional cerebral blood flow, ABPM parameters, and indicators of cognitive functions after 6 months of antihypertensive therapy in patients with MetS. Conclusion: The study showed the presence of diffuse disturbances in cerebral perfusion is associated with cognitive disorders in patients with metabolic syndrome. Combination antihypertensive treatment exerts beneficial effects on the 24-h blood pressure profile, increases cerebral blood flow, and improves cognitive function in patients with MetS.

AB - Aims: To investigate the regional cerebral blood flow, cognitive function, and parameters of 24-h arterial blood pressure monitoring in patients with metabolic syndrome before and after combination antihypertensive therapy. Methods: The study involved 54 patients with metabolic syndrome (MetS) investigated by brain single-photon emission computed tomography, 24-h blood pressure monitoring (ABPM), and comprehensive neuropsychological testing before and after 24 weeks of combination antihypertensive therapy. Results: Patients with metabolic syndrome had significantly poorer regional cerebral blood flow compared with control group: by 7% (P = 0.003) in right anterior parietal cortex, by 6% (P = 0.028) in left anterior parietal cortex, by 8% (P = 0.007) in right superior frontal lobe, and by 10% (P = 0.00002) and 7% (P = 0.006) in right and left temporal brain regions, correspondingly. The results of neuropsychological testing showed 11% decrease in mentation (P = 0.002), and 19% (P = 0.011) and 20% (P = 0.009) decrease in immediate verbal and visual memory in patients with MetS as compared with control group. Relationships between the indices of ABPM, cerebral perfusion, and cognitive function were found. Data showed an improvement of regional cerebral blood flow, ABPM parameters, and indicators of cognitive functions after 6 months of antihypertensive therapy in patients with MetS. Conclusion: The study showed the presence of diffuse disturbances in cerebral perfusion is associated with cognitive disorders in patients with metabolic syndrome. Combination antihypertensive treatment exerts beneficial effects on the 24-h blood pressure profile, increases cerebral blood flow, and improves cognitive function in patients with MetS.

KW - Antihypertensive treatment

KW - Brain perfusion

KW - Circadian rhythm of blood pressure

KW - Cognitive function

KW - Metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=84935517839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935517839&partnerID=8YFLogxK

U2 - 10.1111/1755-5922.12136

DO - 10.1111/1755-5922.12136

M3 - Article

C2 - 25988865

AN - SCOPUS:84935517839

VL - 33

SP - 209

EP - 215

JO - Cardiovascular Therapeutics

JF - Cardiovascular Therapeutics

SN - 1755-5914

IS - 4

ER -